Longitudinal MRI in progressive supranuclear palsy: a new combined score for clinical trials

BACKGROUND: Two recent randomized, placebo-controlled phase II/III trials (clinicaltrials.gov: NCT01110720, NCT01049399) of davunetide and tideglusib in progressive supranuclear palsy (PSP) generated prospective, 1-year longitudinal datasets of high-resolution T1-weighted 3D MRI. OBJECTIVES: Develop...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Mov Disord
Main Authors: Höglinger, Günter U., Schöpe, Jakob, Stamelou, Maria, Kassubek, Jan, del Ser, Teodoro, Boxer, Adam L, Wagenpfeil, Stefan, Huppertz, Hans-Jürgen
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808453/
https://ncbi.nlm.nih.gov/pubmed/28436538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mds.26973
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki